v3 Template
T

TG Therapeutics, Inc.

Biopharmaceuticals / Healthcare New York, USA ~120 employees
Founded
--
Employees (Est.)
~120
8 leaders known
Total Funding
$750.0M
Funding Rounds
2
Last Funding
2026-03-19

About TG Therapeutics, Inc.

TG Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases, with a particular emphasis on relapsing forms of multiple sclerosis (MS). Their mission is to advance innovative therapies to improve patient outcomes.

Products & Services

BRIUMVI (ublituximab-xiiy):An FDA-approved treatment for relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
Ublituximab:A product in the pipeline, focused on treating B-cell related diseases.
Azer-Cel:A pipeline therapy under development for potential therapeutic applications.
TG-1701:A pipeline drug candidate being developed for B-cell disorders.

Specialties

B-cell malignancies treatment Autoimmune disease therapies Multiple Sclerosis (MS) treatments

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 500000000
MR: -
FA: $500 million
FAN: 500000000
D: 2026-03-19
FD: 2026-03-19
1 investors
2 RT: Debt Financing (Term Loan)
T: -
FT: Debt Financing (Term Loan)
A: 250000000
MR: -
FA: $250 million
FAN: 250000000
D: 2024-08-06
FD: 2024-08-06
2 investors
Debt Latest
2026-03-19
$500.0M
1 investor (Pro only)
Debt Financing (Term Loan) 2024-08-06
$250.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael S. Weiss

Chairman, President, and Chief Executive Officer

S

Sean A. Power

Chief Financial Officer

A

Adam Waldman

Chief Commercialization Officer

L

Laurence N. Charney

Board Member

Y

Yann Echelard

Operating Partner at Flagship Pioneering

K

Kenneth Hoberman

Board Member

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

TG Therapeutics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals / Healthcare
Company Size
~120 employees (est.)
Locations
New York, USA
New York

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro